Product
CHEP
1 clinical trial
3 indications
Indication
lymphomaIndication
Adult T-Cell Leukemia/LymphomaIndication
Lymphatic DiseasesClinical trial
Brentuximab Vedotin With Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the Treatment of Adult T-Cell Leukemia/Lymphoma: A Pilot Study of the Rare Lymphoma Working GroupStatus: Active (not recruiting), Estimated PCD: 2023-12-15